Time To Fight Back?

[kmall]

While Geron is on a wild hiring frenzy, perhaps they should consider hiring a former FBI Director to lead a task force investigating alleged illegal trading in their stock as Genius (GNS) CEO Roger Hamilton has done. He understands that naked short selling takes value away from shareholders. This article from MarketWatch last week popped up after David from the YMB had mentioned GNS and it's 200+% increase in the SP since doing so....

"The company is fighting back “because we want this to stop,” Hamilton told MarketWatch. “They’re taking value away from our shareholders. They’re predators. They’re doing something illegal, and we want it to stop, whether that means getting regulators to enforce existing regulations or put new ones in place.”

Public companies have to have committees to monitor and report internal fraud to protect shareholders, he said. But there is no such team looking for external fraud and many retail investors see stocks being manipulated, he said.

“Hopefully, regulations will change and regulators will see there are as many, if not more, threats from outside a company,” he said.

Genius Group is not alone, said Hamilton."

https://www.google.com/amp/s/www.market ... 1674243477

https://www.marketwatch.com/story/geniu ... eid=yhoof2


*Just a little food for thought. It would be nice to finally see Geron free of this apparent gorilla on it's back, that's been here just about if not longer than I have. -Kmall

[LWS]

*Just a little food for thought. It would be nice to finally see Geron free of this apparent gorilla on it's back, that's been here just about if not longer than I have. -Kmall

I believe John Scarlett (JS) is well aware of all the forms of manipulations that threaten a small biotech company. He has defended numerous lawsuits against him and Geron over the years and knows that the 'predators' are following him closely waiting for any stumble or signs of weakness on his part or Geron's. He has to be very careful about what he says and what he presents.

I have much more to say about the 'predators' and their manipulations, but it is all about politics and corruption. This board, I believe, is not the proper place to do that. The "gorilla", unfortunately, is alive and well.

[kmall]

While I do agree that Imetelchat isn't necessarily the board to discuss the SP and any potential manipulation of the SP, it does and has presented itself here from time to time. As far as past lawsuits are concerned, there is a difference between settling and defending. I wouldn't consider settling a lawsuit - "defending" - one by any means, but then again I'm not an attorney. The point of a CEO being proactive against blatant manipulation against a company's SP is apparently gaining traction with CEO's in several industries of various sectors. Biotechs are one of the most prone to this form of attack. Roger Hamilton hired a former FBI Director and by doing so was able to realize an almost immediate 200+% gain for shareholders. I find it admirable that a CEO takes it upon himself to right any wrongs he sees in the form of an attack against him, his company, his employees and his shareholders. I think it's a trend we will see in the very near future. -Kmall

[biopearl123]

Totally legit to have this conversation here. bp

[mistergern]

Anyone who has followed this stock for a significant period of time would have had to recognize SP manipulation that could only be explained by pervasive, unlimited Naked Shorting. In all probability, Geron shareholders have been victimized similarly to the GNS shareholders. I will absolutely support a collective effort to remedy this situation.

[kmall]

Mistergern - for whatever it's worth, I plan on emailing Geron on this subject. There seems to be some traction on the YMB with several regular long posters voicing their concerns. I'll make sure to post my email in this thread and any subsequent reply from Geron. Anyone else who feels as I do, should consider doing the same. -Kmall

[stanleyock]

Kmall, hearing you. Will update if receive response. Thank you so much for all yr pro-active activism that hopefully someday will give birth to Geron Activists Shareholders Investors. Individually we are minute but collectievly believe we can be a force to reckon with.

Hi Aron Feingold,

Its about time something be done to curtail the illegal "Naked Shorts" activities that blatantly defy security rules in depressing the intrinsic value of Geron Share all these years. The sheer disregard and absolute contempt for securities laws by these shenanigans ripping off billions if not millions depriving promising companies the needed funding to realise its full potential to benefit societies is a manifest of the inability of the authority alone to rid these scumbags and scourges. In the aftermath of the last financial crisis in 2009, SEC sets up robust enforcement to deter securities fraud that poses a great challenge to free market economy and whole way of life built on trust in the markets and in our fellow beings. SEC can only act when misconducts are reported. Therefore "A WHOLE OF SOCIETY APPROACH!" is imperative from Individuals, shareholders, companies, associations to communities in this fight to banish these financial scoundrels and leeches. I humbly ask that you read the article from Kmall on Imetelchat forum as attached to demonstrate what Geron as a company can do in its absolute capacity especially now it is on a hiring spree to build a strong workforce in anticipation of FDA approval and commercialisation of Imetelstat.

Would appreciate a feedback.

Thank you Aron!

Warmest regards

Stanleyock (Longtime investor based in Singapore)

[kmall]

Dear Aron Feingold and Geron Board of Directors,

I have been an investor in Geron for over nine years. During this time I have noticed trading patterns with regards to Geron's Stock Price which have all of the hallmarks of "naked short trading," resulting in a continual downward pressure on the stock price. This in turn erodes shareholder value and more importantly suppresses a company's Market Cap. With regards to a Biotech like Geron focused on treating cancer patients, these manipulative and illegal actions can have even greater ramifications in terms of effects on being able to fund additional Clinical Trials, which then harm patients who are desperately in need of treatment. As a former caregiver for a loved one who passed away from a Hematological Disease this is extremely bothersome and concerning to me and many of my fellow shareholders.


https://en.m.wikipedia.org/wiki/Naked_short_selling


Recently several small to mid-cap sized companies have taken it upon themselves to take action against this illegal activity. From the hiring of a former FBI Director in the case of Genius Group Ltd. (GNS) to contracting Independent third party Stock Surveillance companies like ShareIntel, CEO's and their shareholders are fighting back against these blatant and harmful attacks by going on the offensive. Many of these companies have seen an immediate escalation in the SP by 200% or more, merely through a PR mentioning their intentions of doing so.


https://www.google.com/amp/s/www.market ... 1674243477


https://www.marketwatch.com/story/geniu ... eid=yhoof2


https://shareintel.com/


With so much at stake for Geron moving forward in the Hematological Disorder space, and the vital importance of Imetelstat as a paradigm shifting platform drug, Geron the company and it's long term investors deserve to stand on a level playing field once and for all, where market and shareholder value are free of the immoral and illegal manipulation which has plagued this company for almost as long as I've been invested here. I implore both you and Dr. Scarlett to take a stand for future patients of Imetelstat and shareholders like myself who have stood by and supported Geron and it's management through some very trying times.

Thank you in advance for your consideration and attention to this matter.

Kmall
Geron Shareholder since 2014

[biopearl123]

No one can say you don’t know how to write a really good letter! Thanks on behalf of all of us. bp

[Ryan]

Imo: without trying to say I have any knowledge or understanding of these type of operations, or even speculating on whether their is an impact of PPS, *currently* -

It’s nonsensical to think the company (Geron) should focus or allocate resources towards this. If you believe there is a material concern here, I would say allow the company to focus on NDA, Commercialization, Funding for Commercialization and new research (check), that will be a torch to the short tinder.

Imetelstat is safe and effective, that should be the company’s focus.

[LWS]

Imetelstat is safe and effective, that should be the company’s focus----(from Ryan)

I believe both are necessary. The focus should be on Imetelstat and its very important and positive features. On the other hand, Geron cannot ignore the fight, since they are one of the main victims. This is a chance to get away from "the gorilla's" control and have a fairer marketplace. I think Kmall has struck the right tone.

[kmall]

Ryan- while I value your opinion on the subject, and agree that the overall priority for Geron should be the approval/commercialization of Imetelstat, Geron has in fact already "allocated" a tremendous amount of resources settling a "nonsensical" lawsuit. To the tune of $24M, of which I believe Geron forked over $7M or so after insurance covered the rest. Not to mention the numerous public offerings since becoming independent in 2018, which in turn waters down your investment. If Geron's SP wasn't an easy target for flagrant manipulation perhaps fewer rounds of these offerings may have taken place with far fewer outstanding shares available. All of these things do add up and in turn can strain the focus and resources on Clinical Trials and other company objectives, which in the long term harms not only patients and investors, but Geron's reputation as well. -Kmall

[LWS]

Fight Back

The more that I think about it, the more that I believe Geron and others should fight back in all ways possible. Considering the continuing good news about Imetelstat and its potential in combinations, Geron's PPS should not be held down by questionable or illegal activities (naked shorts, false information, computer algorithms, etc.). This is particularly true for many small biotech stocks.

There should at least be 'a level playing field'. I suspect the SEC is well-aware of these types of activities. Unfortunately, there is little (or nothing) we can do individually, especially in this upside-down political environment.

Of course, getting approvals (from FDA, EMA, MHRA//UK) is most important, but should be kept in proper perspective.

[kmall]

LWS- Geron certainly has the money to send employees on feel good retreats. Taking a proactive stance against a corporate attack through stock manipulation would/should be a top priority in my view. -Kmall

[kmall]

Kudos once again to David over on the YMB. He has been mentioning Wes Christian, a Houston based attorney specializing in going after perpetrators behind illegal naked short manipulation. This article covers a multitude of tactics used by these financial predators and ways to combat them. Interestingly enough, it costs approximately $7M to prosecute a case - the same amount Geron just forked over to settle a nonsensical lawsuit a few months ago (insurance for Geron covered $17M of the $24M total).

“We take cases on a contingency basis. It costs even at our level $7 million to prosecute a case. We need a high damage model. Typically, we represent the company and its largest shareholders.” He explained, “We need a damage model of at least $100 million. The issuer has the largest damages.”

Another point of interest for those of you who feel this doesn't affect every ACTUAL shareholder here:

"......the company (Geron) should do what Overstock and Taser did, figure out who is responsible and sue them. In most states, if a corporation won’t do it, shareholders can derivatively do it. THEY HAVE BEEN DAMAGED BY THE DILUTION OF THEIR SHARES." -Kmall

https://www.thekomisarscoop.com/2021/07 ... t-sellers/

[kmall]

Genius Group Ltd. (GNS) is now up 2,100%, since announcing that they would hire former FBI Director Timothy Murphy to lead a task force investigating alleged illegal trading in its stock. -Kmall